Live Breaking News & Updates on Induction Study

Stay updated with breaking news from Induction study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

InDex Pharmaceuticals provides complementary information on the phase III program CONCLUDE with cobitolimod

STOCKHOLM, Feb. 14, 2023 /PRNewswire/ InDex Pharmaceuticals Holding AB (publ) is today making a presentation with CEO Jenny Sundqvist available in light of the press release issued January ....

Dennis Riedl , Johan Gil , Jenny Sundqvist , Prnewswire Index Pharmaceuticals Holding , Kindex Pharmaceuticals , Induction Study , Dex Pharmaceuticals , Immunomodulatory Sequences , Nasdaq First North Growth Market , Addex Pharma ,